ArticleScientific reports2022

Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.

Giulia Falconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.